PROM1 and colorectal carcinoma: We revealed that metformin in combination with 5-FU significantly decreased both the proportion of CD133+ cells and the expression of β-catenin protein, indicating metformin might have a synergistic antineoplastic effect on CRC by inhibting the proliferation of CSCs via the β-catenin pathway.